(BMRN) Biomarin Pharmaceutical complete technical analysis [charts+indicators] | Buy/Sell Biomarin Pharmaceutical | (BMRN) share price targets
Complete technical analysis of Biomarin Pharmaceutical (BMRN) by charts plus indicators, forecast predictions and share price targets for Biomarin Pharmaceutical (BMRN)
Biomarin Pharmaceutical trades in USA in Health Care sector.
10 day averaged volume of Biomarin Pharmaceutical is 1544520
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Thu Apr 2025 | 67.48 | 67.83 | 68.54 | 67.28 | 1.187 times |
| 02 Wed Apr 2025 | 68.32 | 67.86 | 69.87 | 67.47 | 0.938 times |
| 01 Tue Apr 2025 | 67.94 | 70.36 | 70.63 | 67.84 | 0.84 times |
| 31 Mon Mar 2025 | 70.69 | 70.61 | 71.28 | 69.05 | 1.068 times |
| 28 Fri Mar 2025 | 71.44 | 72.59 | 72.81 | 70.82 | 0.806 times |
| 24 Mon Mar 2025 | 71.99 | 71.29 | 72.37 | 71.29 | 0.949 times |
| 21 Fri Mar 2025 | 71.24 | 71.55 | 72.06 | 70.68 | 2.005 times |
| 20 Thu Mar 2025 | 71.60 | 71.09 | 72.24 | 70.82 | 0.878 times |
| 19 Wed Mar 2025 | 71.32 | 71.52 | 72.08 | 70.92 | 1.165 times |
| 18 Tue Mar 2025 | 71.52 | 71.27 | 72.18 | 70.83 | 0.756 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 67.8, for a target of 69.3 or 70.67
Share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Target | 60.63 |
| Downside Target | 63.98 |
| Downside Target | 67.28 |
| Upside Target | 70.82 |
| Upside Target | 71.28 |
| Upside Target | 71.58 |
| Upside Target | 72.24 |
| Upside Target | 72.81 |
| Upside Target | 72.99 |
| Upside Target | 73.51 |
Intraday share price targets for Biomarin Pharmaceutical (BMRN)
| Target Type | Value |
| Downside Intraday Target | 66.08 |
| Downside Intraday Target | 64.68 |
| Upside Intraday Target | 70.08 |
| Upside Intraday Target | 72.68 |
| Upside Intraday Target | 68.68 |
Weekly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Thu Apr 2025 | 67.48 | 70.61 | 71.28 | 67.28 | 2.297 times |
| 28 Fri Mar 2025 | 71.44 | 71.29 | 72.81 | 70.82 | 0.325 times |
| 21 Fri Mar 2025 | 71.24 | 69.60 | 72.24 | 69.23 | 1.362 times |
| 14 Fri Mar 2025 | 69.44 | 72.85 | 72.99 | 68.42 | 0.88 times |
| 07 Fri Mar 2025 | 72.23 | 71.07 | 73.51 | 69.89 | 0.912 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Biomarin Pharmaceutical (BMRN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Thu Apr 2025 | 67.48 | 70.36 | 70.63 | 67.28 | 0.178 times |
| 31 Mon Mar 2025 | 70.69 | 71.07 | 73.51 | 68.42 | 0.924 times |
| 28 Fri Feb 2025 | 71.16 | 62.55 | 71.58 | 61.71 | 0.719 times |
| 31 Fri Jan 2025 | 63.36 | 65.97 | 69.70 | 60.63 | 2.079 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biomarin Pharmaceutical (BMRN)
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 70.38 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Biomarin Pharmaceutical ( (BMRN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Biomarin Pharmaceutical in short term but the sell signal is initial and weak.
Biomarin Pharmaceutical Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Biomarin Pharmaceutical in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biomarin Pharmaceutical is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 70.38 and Biomarin Pharmaceutical (BMRN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Biomarin Pharmaceutical (BMRN) stock. Volume based technical analysis of Biomarin Pharmaceutical (BMRN) stock is negative.
Biomarin Pharmaceutical Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.